<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">82395</article-id><article-id pub-id-type="doi">10.7554/eLife.82395</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group></article-categories><title-group><article-title>Inactivation of <italic>Invs</italic>/<italic>Nphp2</italic> in renal epithelial cells drives infantile nephronophthisis like phenotypes in mouse</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-289130"><name><surname>Li</surname><given-names>Yuanyuan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-289131"><name><surname>Xu</surname><given-names>Wenyan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-289132"><name><surname>Makova</surname><given-names>Svetlana</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-80550"><name><surname>Brueckner</surname><given-names>Martina</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-166218"><name><surname>Sun</surname><given-names>Zhaoxia</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2307-7719</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Genetics</institution>, <institution>Yale University</institution>, <addr-line><named-content content-type="city">New Haven</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Pediatrics</institution>, <institution>Yale University</institution>, <addr-line><named-content content-type="city">New Haven</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Department of Genetics</institution>, <institution>Yale University</institution>, <addr-line><named-content content-type="city">new haven</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-41509"><name><surname>Germino</surname><given-names>Gregory G</given-names></name><role>Reviewing editor</role><aff><institution>National Institutes of Health</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>zhaoxia.sun@yale.edu</email> (ZS);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>15</day><month>03</month><year>2023</year></pub-date><volume>12</volume><elocation-id>e82395</elocation-id><history><date date-type="received"><day>02</day><month>08</month><year>2022</year></date><date date-type="accepted"><day>14</day><month>03</month><year>2023</year></date></history><permissions><copyright-statement>Â© 2023, Li et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Li et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-82395-v1.pdf"/><abstract><p>Nephronophthisis (NPHP) is a ciliopathy characterized by renal fibrosis and cyst formation, and accounts for a significant portion of end stage renal disease in children and young adults. Currently no targeted therapy is available for this disease. <italic>INVS/</italic><italic>NPHP2</italic> is one of the 25 NPHP genes identified to date. In mouse, global knockout of <italic>Invs</italic> leads to renal fibrosis and cysts. However, the precise contribution of different cell types and the relationship between epithelial cysts and interstitial fibrosis remains undefined. Here, we generated and characterized cell-type specific knockout mouse models of <italic>Invs</italic>, investigated the impact of removing cilia genetically on phenotype severity in <italic>Invs</italic> mutants and evaluated the impact of the histone deacetylase inhibitor valproic acid (VPA) on <italic>Invs</italic> mutants. Epithelial specific knockout of <italic>Invs</italic> in <italic>Invs<sup>flox/flox</sup>;Cdh16-Cre</italic> mutant mice resulted in renal cyst formation and severe stromal fibrosis, while <italic>Invs<sup>flox/flox</sup>;Foxd1-Cre</italic> mice, where <italic>Invs</italic> is deleted in stromal cells, displayed no observable phenotypes up to the young adult stage, highlighting a significant role of epithelial-stromal crosstalk. Further, increased cell proliferation and myofibroblast activation occurred early during disease progression and preceded detectable cyst formation in the <italic>Invs<sup>flox/flox</sup>;Cdh16-Cre</italic> kidney. Moreover, concomitant removal of cilia partially suppressed the phenotypes of the <italic>Invs<sup>flox/flox</sup>;Cdh16-Cre</italic> mutant kidney, supporting a significant interaction of cilia and <italic>Invs</italic> function <italic>in vivo</italic>. Finally, VPA reduced cyst burden, decreased cell proliferation and ameliorated kidney function decline in <italic>Invs</italic> mutant mice. Our results reveal the critical role of renal epithelial cilia in NPHP and suggest the possibility of repurposing VPA for NPHP treatment.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution>NIH</institution></institution-wrap></funding-source><award-id>R01DK113135</award-id><principal-award-recipient><name><surname>Sun</surname><given-names>Zhaoxia</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution>NIH</institution></institution-wrap></funding-source><award-id>R01HD093608</award-id><principal-award-recipient><name><surname>Sun</surname><given-names>Zhaoxia</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>NIH</institution></institution-wrap></funding-source><award-id>R35HL145249</award-id><principal-award-recipient><name><surname>Brueckner</surname><given-names>Martina</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All mouse experiments were performed in Yale University School of Medicine in accordance with Yale University Institutional Animal Care and Use Committee guidelines.  Protocols were approved by Yale University Institutional Animal care and Use Committee (Protocol number: 2022-11546).</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>No large scale datasets generated. Data analyzed can be found in source data files for figures 1-7, figure 4 figure supplement 1 and figure 7 figure supplement 1.</p></sec><supplementary-material><ext-link xlink:href="elife-82395-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>